Trial Profile
Effectiveness of Oral Insulin in Unstable Type 1 Diabetes Patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 May 2013
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- 01 May 2013 Results published in PLOS ONE journal, according to an Oramed Pharmaceuticals media release.
- 29 Apr 2013 Results presented at the Global Technology Community Diabetes Summit 2013, according to an Oramed Pharmaceuticals media release.
- 10 Aug 2011 Actual end date (Aug 2008) added as reported by ClinicalTrials.gov.